STVN
Stevanato Group SpA
NYSE · Healthcare · Medical - Instruments & Supplies · IT
$13.83
−1.95%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$13.94
From 52W high−44.70%
Volume85818.00
Market cap$3.78B
P/E (TTM)25.8x
P/S (TTM)2.8x
Div yield0.45%
Key dataNov 4, 2026
Open
$13.94
From 52W high
−44.70%
Volume
85818.00
Market cap
$3.78B
ValuationView details →
P/E (Fwd)
18.0x
EV/EBITDA
12.6x
P/E (TTM)
25.8x
RSI (14)
23.1
MomentumView details →
1D Return
−1.95%
YTD Return
−26.27%
SummaryUpdated Jun 1, 2026
Stevanato Group S.p.A. (NYSE:STVN) is an Italian pharmaceutical packaging and equipment company founded in 1949 and headquartered in Piombino Dese, Italy. The company went public in July 2021 and operates as a subsidiary of Stevanato Holding S.R.L. Stevanato has evolved from a traditional glass manufacturer into a leading provider of integrated solutions for the pharmaceutical and healthcare industries, specializing in drug containment, delivery systems, and manufacturing equipment. The company serves global pharmaceutical companies through manufacturing facilities in Italy, the United States, and other international locations.
Similar companies
Latest newsMore news →
Stevanato Group S.p.A. shares declined, prompting a shareholder investigation.1h agoSueWallSt announced a pending investigation into whether Stevanato Group's disclosures to investors complied with U.S. securities laws.16h agoStevanato Group S.p.A. reported quarterly earnings of $0.18 per share, above the Zacks consensus estimate of $0.17 and compared with $0.16 per share a year earlier.1d ago